|


Dear Supporter,
The data is in, and the results are historic. For the first time, the five-year survival rate for all cancers combined has reached 70%.1
While everyone working toward progress in cancer treatment and care has helped to reach this milestone, it is certainly a testament to your commitment as a Conquer Cancer supporter. The researchers Conquer Cancer has funded over the past quarter century have made contributions to this advance through their work in earlier detection and significantly improved treatments, such as targeted therapies and immunotherapies. Supported by your philanthropy, these researchers have played a part in changing the outlook for patients, providing more time and a better quality of life for families across the globe.
From Early Innovation to Lifesaving Solutions
Your generosity means that researchers can move from theories, to studies, to breakthroughs. In 2025 alone, because of support from donors like you, Conquer Cancer provided $12 million toward powering more than 570 Conquer Cancer grants and awards, catalyzing the global oncology workforce and supporting researchers at every stage of their journey.
In the pages of our 2025 Impact Report, you will see how these investments are accelerating progress through the work of visionary leaders and the patients they serve. You will learn how Dr. Thomas Odeny is bridging the gap between cutting-edge discovery and resource-limited settings to develop treatments for rare cancers that benefit patients globally. You will also read about Dr. Yelena Janjigian, whose research was featured at the 2025 ASCO Annual Meeting and now leads an international effort to fast-track treatments for gastroesophageal cancers. Most importantly, you will meet survivors like Molly, whose second chance at life was made possible through an innovative clinical trial led by a Conquer Cancer-funded researcher, Dr. Marina Baretti.
You are the Force Behind the Breakthroughs
These stories of discovery and advancements in care are the result of your generous commitment to our cause. By supporting the work of the brightest minds in oncology as they bring better treatments and cures to people living with cancer, you are a driving force behind the advancements being made.
Thank you for being part of this community. Together, we will conquer cancer.

|

Howard A. Burris III, MD, FACP, FASCO
Chair, Conquer Cancer
|

Nancy R. Daly, MS, MPH
Chief Executive Officer, Conquer Cancer
|

Clifford A. Hudis, MD, FACP, FASCO
Executive Vice Chair, Conquer Cancer;
Chief Executive Officer, ASCO
|
|